{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:40:38Z","timestamp":1764744038815,"version":"3.46.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00109-025-02603-3","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:57:49Z","timestamp":1762786669000},"page":"1599-1610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted metabolomics reveals tricarboxylic acid cycle-related metabolites serve as predictive biomarkers for trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer"],"prefix":"10.1007","volume":"103","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangbang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0393-4223","authenticated-orcid":false,"given":"Xinxin","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2603_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"2603_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"2603_CR3","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.ejca.2008.09.013","volume":"44","author":"W Dean-Colomb","year":"2008","unstructured":"Dean-Colomb W, Esteva FJ (2008) Her2-positive breast cancer: herceptin and beyond. Eur J Cancer 44:2806\u20132812","journal-title":"Eur J Cancer"},{"key":"2603_CR4","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1002\/jcp.29216","volume":"235","author":"A Derakhshani","year":"2020","unstructured":"Derakhshani A, Rezaei Z, Safarpour H, Sabri M, Mir A, Sanati MA, Vahidian F, Gholamiyan Moghadam A, Aghadoukht A, Hajiasgharzadeh K, Baradaran B (2020) Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy. J Cell Physiol 235:3142\u20133156","journal-title":"J Cell Physiol"},{"key":"2603_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(09)61964-4","volume":"375","author":"L Gianni","year":"2010","unstructured":"Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M et al (2010) Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet 375:377\u2013384","journal-title":"Lancet"},{"key":"2603_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1470-2045(06)70906-8","volume":"7","author":"RL Jones","year":"2006","unstructured":"Jones RL, Smith IE (2006) Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 7:869\u2013874","journal-title":"Lancet Oncol"},{"key":"2603_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gm421","volume":"5","author":"PC Guest","year":"2013","unstructured":"Guest PC, Gottschalk MG, Bahn S (2013) Proteomics: improving biomarker translation to modern medicine? Genome Med 5:17","journal-title":"Genome Med"},{"key":"2603_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/14789450.2019.1559062","volume":"16","author":"VA Hristova","year":"2019","unstructured":"Hristova VA, Chan DW (2019) Cancer biomarker discovery and translation: proteomics and beyond. Expert Rev Proteomics 16:93\u2013103","journal-title":"Expert Rev Proteomics"},{"key":"2603_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110465","volume":"129","author":"T Yang","year":"2020","unstructured":"Yang T, Fu Z, Zhang Y, Wang M, Mao C, Ge W (2020) Serum proteomics analysis of candidate predictive biomarker panel for the diagnosis of trastuzumab-based therapy resistant breast cancer. Biomed Pharmacother 129:110465","journal-title":"Biomed Pharmacother"},{"key":"2603_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","volume":"9","author":"NM Anderson","year":"2018","unstructured":"Anderson NM, Mucka P, Kern JG, Feng H (2018) The emerging role and targetability of the TCA cycle in cancer metabolism. Protein Cell 9:216\u2013237","journal-title":"Protein Cell"},{"key":"2603_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M et al (2009) New response evaluation criteria in solid tumours: revised recist guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"2603_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5391832","volume":"2017","author":"O Al Kadhi","year":"2017","unstructured":"Al Kadhi O, Melchini A, Mithen R, Saha S (2017) Development of a LC-MS\/MS method for the simultaneous detection of tricarboxylic acid cycle intermediates in a range of biological matrices. J Anal Methods Chem 2017:5391832","journal-title":"J Anal Methods Chem"},{"key":"2603_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","volume":"12","author":"K Berns","year":"2007","unstructured":"Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M et al (2007) A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell 12:395\u2013402","journal-title":"Cancer Cell"},{"key":"2603_CR14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"TM Phillips","year":"2006","unstructured":"Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(-\/low)\/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777\u20131785","journal-title":"J Natl Cancer Inst"},{"key":"2603_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1167-3","volume":"21","author":"A Hori","year":"2019","unstructured":"Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T, Shimazu K, Kim SJ, Noguchi S (2019) Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res 21:88","journal-title":"Breast Cancer Res"},{"key":"2603_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01533","volume":"10","author":"A Espinosa-S\u00e1nchez","year":"2020","unstructured":"Espinosa-S\u00e1nchez A, Su\u00e1rez-Mart\u00ednez E, S\u00e1nchez-D\u00edaz L, Carnero A (2020) Therapeutic targeting of signaling pathways related to cancer stemness. Front Oncol 10:1533","journal-title":"Front Oncol"},{"key":"2603_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1158\/0008-5472.473.65.2","volume":"65","author":"P Nagy","year":"2005","unstructured":"Nagy P, Friedla\u0308nder E, Tanner M, Kapanen AI, Carraway KL, Isola J, Jovin TM (2005) Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res 65:473\u2013482","journal-title":"Cancer Res"},{"key":"2603_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2049-3002-2-21","volume":"2","author":"PP Aspuria","year":"2014","unstructured":"Aspuria PP, Lunt SY, V\u00e4remo L, Vergnes L, Gozo M, Beach JA, Salumbides B, Reue K, Wiedemeyer WR, Nielsen J et al (2014) Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab 2:21","journal-title":"Cancer Metab"},{"key":"2603_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nature20144","volume":"540","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Gon\u00e7alves E, Johnson TI, Zecchini VR, da Costa AS, Gaude E, Drubbel AV, Theobald SJ, Abbo SR, Tran MG et al (2016) Corrigendum: fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 540:150","journal-title":"Nature"},{"key":"2603_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"2603_CR21","doi-asserted-by":"crossref","unstructured":"Laukka T, Mariani CJ, Ihantola T, Cao JZ, Hokkanen J, Kaelin WG Jr., Godley LA, Koivunen P (2016) Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J Biol Chem 291:4256\u20134265","DOI":"10.1074\/jbc.M115.688762"},{"key":"2603_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biochi.2017.01.004","volume":"135","author":"JF Wentzel","year":"2017","unstructured":"Wentzel JF, Lewies A, Bronkhorst AJ, van Dyk E, du Plessis LH, Pretorius PJ (2017) Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in vitro. Biochimie 135:28\u201334","journal-title":"Biochimie"},{"key":"2603_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082266","author":"O Zidi","year":"2021","unstructured":"Zidi O, Souai N, Raies H, Ben Ayed F, Mezlini A, Mezrioui S, Tranchida F, Sabatier JM, Mosbah A, Cherif A et al (2021) Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers. Molecules. https:\/\/doi.org\/10.3390\/molecules26082266","journal-title":"Molecules"},{"key":"2603_CR24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.molcel.2022.01.029","volume":"82","author":"X Ge","year":"2022","unstructured":"Ge X, Li M, Yin J, Shi Z, Fu Y, Zhao N, Chen H, Meng L, Li X, Hu Z et al (2022) Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Mol Cell 82:1249-1260.e1247","journal-title":"Mol Cell"},{"key":"2603_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00280-017-3475-6","volume":"81","author":"LC Phua","year":"2018","unstructured":"Phua LC, Goh S, Tai DWM, Leow WQ, Alkaff SMF, Chan CY, Kam JH, Lim TKH, Chan ECY (2018) Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine. Cancer Chemother Pharmacol 81:277\u2013289","journal-title":"Cancer Chemother Pharmacol"},{"key":"2603_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41589-022-01085-5","volume":"18","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhou H, Wu L, Lai Z, Geng D, Yang W, Zhang J, Fan Z, Qin W, Wang Y et al (2022) O-glcnacylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1. Nat Chem Biol 18:1087\u20131095","journal-title":"Nat Chem Biol"},{"key":"2603_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35:427\u2013433","journal-title":"Trends Biochem Sci"},{"key":"2603_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033","journal-title":"Science"},{"key":"2603_CR29","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1021\/acs.jproteome.0c00285","volume":"19","author":"L You","year":"2020","unstructured":"You L, Fan Y, Liu X, Shao S, Guo L, Noreldeen HAA, Li Z, Ouyang Y, Li E, Pan X et al (2020) Liquid chromatography-mass spectrometry-based tissue metabolic profiling reveals major metabolic pathway alterations and potential biomarkers of lung cancer. J Proteome Res 19:3750\u20133760","journal-title":"J Proteome Res"},{"key":"2603_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098581","volume":"9","author":"H Hur","year":"2014","unstructured":"Hur H, Paik MJ, Xuan Y, Nguyen DT, Ham IH, Yun J, Cho YK, Lee G, Han SU (2014) Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS ONE 9:e98581","journal-title":"PLoS ONE"},{"key":"2603_CR31","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s12010-015-1706-z","volume":"176","author":"Q Liang","year":"2015","unstructured":"Liang Q, Wang C, Li B (2015) Metabolomic analysis using liquid chromatography\/mass spectrometry for gastric cancer. Appl Biochem Biotechnol 176:2170\u20132184","journal-title":"Appl Biochem Biotechnol"},{"key":"2603_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1514-5","volume":"15","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang CH, Zhang YF, Zhu L, Lei HM, Tang YB (2019) UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells. Metabolomics 15:52","journal-title":"Metabolomics"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02603-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:38:42Z","timestamp":1764743922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2603"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02603-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"type":"print","value":"0946-2716"},{"type":"electronic","value":"1432-1440"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Jiangsu Cancer Hospital approved the study, which was conducted according to the Declaration of Helsinki of the World Medical Association. Written informed consent was obtained from all the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}